Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study

MLA

Katrine Finderup Nielsen, et al. Vaccine Effectiveness against SARS-CoV-2 Reinfection during Periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) Dominance: A Danish Nationwide Study. June 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b6042e857d9e11d5f15b82caee0e585e&authtype=sso&custid=ns315887.

APA

Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, Michael Asger Andersen, Marianna Meaidi, Jan Wohlfahrt, & Palle Valentiner-Branth. (2022). Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide study.

Chicago

Katrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, Mie Agermose Gram, Hanne-Dorthe Emborg, Jens Nielsen, Christian Holm Hansen, et al. 2022. “Vaccine Effectiveness against SARS-CoV-2 Reinfection during Periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) Dominance: A Danish Nationwide Study,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b6042e857d9e11d5f15b82caee0e585e&authtype=sso&custid=ns315887.